PHARMALEX
ActiveSummary
PHARMALEX has been active since 2000 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.9m and a net result of €64,882. Equity remains stable across the filed financial years (±2.3% per year). Its solvency ranks better than 88% of 1,056 sector peers (NACE 69, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
- Staff
- 15 FTE
- Equity
- €1.9m
- Profit
- €64,882
- Parent
- AMARRIS HOLDING.BE · 100%
- AMARRIS HOLDING.BEDirector · permanent representative ROBIN Claude Gilbert André
Why 95raises riskSize: 15 FTE, total assets €2.3mlowers riskSector: Legal and accounting activities (NACE 69)Liquidity: current ratio 6.37, cash €431,662Equity €1.9m (84.3% of total assets)Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 69, small): better than 86% on solvency, 80% on liquidity, 31% on profitability and 34% on growth.
The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 7 accounts on average 45 days before the deadline; the sector median (NACE 69) for financial year 2024 is 9 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
- Resignations: MEULEMAN Philippe Charles Louis (director)…Appointment: AMARRIS HOLDING.BE (director) ·…
- Annual accounts filedfinancial year 2025 · full…
- Weakest financial yearnet €64,882 ▼62.7%
Financials · financial year 2025, full format
2021 to 2025, 5 financial years 2018 to 2025, 8 financial years
The operating result has fallen two years in a row; 2025 is 65% below 2024 and is the lowest result in the available series.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
How much of each euro of turnover is left from operations (EBIT margin) and what the assets earn (return on assets).
The share of the company financed with its own means. The higher it is, the better it absorbs a shock.
Short-term assets per euro of short-term debt. Above 1 the short-term debts are covered.
Average staff in full-time equivalents (FTE).
Use the arrow keys on the chart for the figures per year.
Sector: the middle half of NACE 69, Legal and accounting activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).
- 2024 Net result -53% on 2023. The accounts now follow the full format, last year the abbreviated format.
- 2023 Net result +109% on 2022. The previous financial year ran 6 months, this one 12. The accounts now follow the abbreviated format, last year the full format.
- 2022 Net result -75% on 2021. This financial year ran 6 months, the previous one 12.
Peer companies
Historical observationOf the 14,766 companies that looked in July 2024 the way this one looks now, 0.2% went bankrupt within 24 months and 96.2% are still going.
- Small
- 20 years or older
- solvency 30% or more
- a profit under 5% of the balance sheet
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of < 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 14,766 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Turnover70 | - | - | - | - | - | €1.9m | - | - | - |
| Goods, raw materials, services and sundry goods60/61 | - | - | - | - | - | €0.6m | - | - | - |
| Remuneration, social security and pensions62 | - | - | - | - | €0.4m | €0.8m | €1.0m | €1.1m | ▲ 10.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €0.03m | €0.03m | €0.03m | €454 | €227 | €484 | €0.002m | €0.002m | ▲ 2.4% |
| Other operating charges640/8 | - | - | - | - | €36 | €0.001m | €0.001m | €0.006m | ▲ 527% |
| Non-recurring operating charges66A | - | - | - | - | - | - | - | €0.003m | - |
| Gross operating margin9900 | €1.4m | €1.4m | €1.4m | €1.5m | €0.6m | €1.2m | €1.2m | €1.2m | ▼ 4.9% |
| Operating profit (loss)9901 | €0.7m | €0.8m | €0.7m | €0.9m | €0.2m | €0.5m | €0.3m | €0.09m | ▼ 65.0% |
| Financial income75/76B | - | - | - | - | €0.002m | €0.01m | €0.008m | €0.01m | ▲ 65.9% |
| Recurring financial income75 | €0.008m | €0.008m | €0.01m | €0.06m | €0.002m | €0.01m | €0.008m | €0.01m | ▲ 65.9% |
| Financial charges65/66B | - | - | - | - | €0.001m | €0.001m | €0.005m | €0.003m | ▼ 40.6% |
| Recurring financial charges65 | €0.04m | €0.04m | €0.05m | €0.03m | €0.001m | €0.001m | €0.005m | €0.003m | ▼ 40.6% |
| Profit (loss) for the period before taxes9903 | €0.6m | €0.7m | €0.7m | €0.9m | €0.2m | €0.5m | €0.3m | €0.1m | ▼ 61.4% |
| Income taxes67/77 | €0.2m | €0.2m | €0.2m | €0.2m | €0.06m | €0.1m | €0.08m | €0.03m | ▼ 58.5% |
| Profit (loss) for the period9904 | €0.4m | €0.5m | €0.5m | €0.7m | €0.2m | €0.4m | €0.2m | €0.06m | ▼ 62.7% |
| Transfer from tax-exempt reserves789 | - | - | - | - | €0.04m | €0.1m | €0.09m | - | - |
| Transfer to tax-exempt reserves689 | - | - | - | - | - | €0.06m | €0.06m | €0.03m | ▼ 47.6% |
| Profit (loss) for the period to be appropriated9905 | €0.3m | €0.5m | €0.5m | €0.8m | €0.2m | €0.4m | €0.2m | €0.03m | ▼ 84.1% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total assets20/58 | €2.5m | €2.7m | €3.0m | €2.9m | €2.4m | €2.6m | €2.5m | €2.3m | ▼ 10.0% |
| Fixed assets21/28 | €0.06m | €0.03m | €0.01m | €499 | €0.8m | €0.8m | €0.007m | €0.006m | ▼ 21.1% |
| Tangible fixed assets22/27 | €0.06m | €0.03m | €0.01m | €499 | €272 | €0.006m | €0.007m | €0.006m | ▼ 21.1% |
| Plant, machinery and equipment23 | - | - | - | - | - | - | €0.002m | €0.002m | ▼ 10.9% |
| Furniture and vehicles24 | - | - | - | - | €272 | €0.006m | €0.005m | €0.004m | ▼ 26.1% |
| Financial fixed assets28 | - | - | - | - | €0.8m | €0.8m | - | - | - |
| Current assets29/58 | €2.4m | €2.6m | €3.0m | €2.9m | €1.6m | €1.8m | €2.5m | €2.3m | ▼ 9.9% |
| Amounts receivable within one year40/41 | €0.9m | €0.9m | €0.8m | €0.6m | €0.8m | €1.3m | €2.2m | €1.8m | ▼ 17.2% |
| Trade receivables40 | - | - | - | - | €0.7m | €0.7m | €0.9m | €0.6m | ▼ 33.1% |
| Other amounts receivable41 | - | - | - | - | €0.04m | €0.6m | €1.2m | €1.2m | ▼ 5.2% |
| Current investments50/53 | €0.5m | €0.8m | €0.8m | - | - | - | - | - | - |
| Cash at bank and in hand54/58 | €1.0m | €1.0m | €1.4m | €2.3m | €0.8m | €0.4m | €0.3m | €0.4m | ▲ 33.9% |
| Deferred charges and accrued income490/1 | - | - | - | - | €0.02m | €0.02m | €0.01m | €0.03m | ▲ 117% |
| Equity and liabilities | |||||||||
| Total equity and liabilities10/49 | €2.5m | €2.7m | €3.0m | €2.9m | €2.4m | €2.6m | €2.5m | €2.3m | ▼ 10.0% |
| Equity10/15 | €1.1m | €1.6m | €2.0m | €1.9m | €1.9m | - | €1.9m | €1.9m | ▲ 1.0% |
| Contributions10/11 | €0.02m | €0.02m | - | - | €0.02m | €0.02m | €0.02m | €0.02m | = |
| Reserves13 | €1.1m | €1.2m | €1.1m | €1.9m | €1.9m | €1.9m | €1.9m | €1.9m | ▲ 1.8% |
| Non-distributable reserves130/1 | - | - | - | - | €0.8m | €0.8m | €0.8m | €0.8m | = |
| Reserves not available under the articles1311 | - | - | - | - | - | €0.8m | €0.8m | €0.8m | = |
| Financial assistance1313 | - | - | - | - | €0.8m | - | - | - | - |
| Tax-exempt reserves132 | - | - | - | - | €0.2m | €0.2m | €0.1m | €0.2m | ▲ 26.2% |
| Distributable reserves133 | - | - | - | - | €0.9m | €1.0m | €0.9m | €0.9m | = |
| Profit (loss) carried forward14 | €0.006m | €0.5m | €0.9m | €0.02m | €177 | €0.003m | €0.02m | €0.007m | ▼ 66.0% |
| Amounts payable17/49 | €1.3m | €1.0m | €1.0m | €0.9m | €0.5m | €0.6m | €0.6m | €0.4m | ▼ 43.2% |
| Amounts payable within one year42/48 | €1.3m | €1.0m | €1.0m | €0.9m | €0.5m | €0.6m | €0.6m | €0.4m | ▼ 43.2% |
| Trade debts44 | €0.04m | €0.04m | €0.04m | €0.07m | €0.1m | €0.2m | €0.2m | €0.1m | ▼ 55.2% |
| Suppliers440/4 | - | - | - | - | €0.1m | €0.2m | €0.2m | €0.1m | ▼ 55.1% |
| Bills of exchange payable441 | - | - | - | - | - | - | €0.001m | - | - |
| Advances received on contracts in progress46 | - | - | - | - | - | €0.03m | €0.002m | - | - |
| Taxes, remuneration and social security45 | - | - | - | - | €0.2m | €0.1m | €0.1m | €0.2m | ▲ 43.3% |
| Taxes450/3 | - | - | - | - | €0.05m | €0.03m | €0.04m | €0.05m | ▲ 25.2% |
| Remuneration and social security454/9 | - | - | - | - | €0.1m | €0.08m | €0.1m | €0.2m | ▲ 50.7% |
| Other amounts payable47/48 | - | - | - | - | €0.2m | €0.3m | €0.2m | €0.05m | ▼ 81.3% |
| Accrued charges and deferred income492/3 | - | - | - | - | €0.006m | - | - | - | - |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €0.4m | €0.5m | €0.5m | €0.7m | €0.2m | €0.4m | €0.2m | €0.06m | ▼ 62.7% |
| + Depreciation and write-downs630 | €0.03m | €0.03m | €0.03m | €454 | €227 | €484 | €0.002m | €0.002m | ▲ 2.4% |
| Operating cash flow (approximation) | €0.5m | €0.5m | €0.5m | €0.7m | €0.2m | €0.4m | €0.2m | €0.07m | ▼ 62.2% |
| Investment in fixed assets (approximation) | - | €0 | -€0.004m | €0.01m | -€0.8m | -€0.006m | €0.8m | €0 | ▼ 100% |
| Change in cash | - | -€0.08m | €0.5m | €0.9m | -€1.5m | -€0.4m | -€0.08m | €0.1m | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Latest 10 of 26 filings with the National Bank
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 30-06-2025 | full format | 08-01-2026 | 2026-00005255 |
| 30-06-2024 | full format | 19-12-2024 | 2024-00621705 |
| 30-06-2023 | abbreviated format | 25-04-2024 | 2024-00083111 |
| 30-06-2023 | full format | 25-01-2024 | 2024-00007648 |
| 30-06-2022 | full format | 23-12-2022 | 2023-20552485 |
| 31-12-2021 | full format | 28-03-2022 | 2022-08700540 |
| 31-12-2020 | full format | 31-05-2021 | 2021-16200284 |
| 31-12-2019 | full format | 16-07-2020 | 2020-31000442 |
| 31-12-2018 | full format | 29-03-2019 | 2019-08700355 |
| 31-12-2017 | full format | 27-06-2018 | 2018-24900382 |
Similar companies · same sector, comparable size
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Board 1
Permanent representatives 1
Statutory auditor 1
Not every act has been read: a resignation may still be missing
Mandate history
- Board
- Statutory auditor
- began earlier
| Name | Functions and periods |
|---|---|
| AMARRIS HOLDING.BE |
|
| CDP PETIT & Co |
|
| BERNARD Guy Ivan Marc |
|
| MEULEMAN Philippe Charles Louis |
|
Owners and capital
Owners
2 ownersChain of control
- AMARRIS HOLDING SASFR
- AMARRIS HOLDING.BE
- PHARMALEX
Highest known parent: AMARRIS HOLDING SAS (France). The sources do not say who stands above it.
Owners 2
-
100%
- AMARRIS HOLDING SASFRconsolidating parentconsolidates
Sources: the companies' annual accounts, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Capital and shareholders
- 03-08-2026 Capital stated in the deed · 200 shares
Group and network
Connections & network
1 current directorThe network starts from this company’s directors. Other companies they run appear here as nodes.
History
Acts, filings and financial milestones
03-08
Gazette deed
Resignations: MEULEMAN Philippe Charles Louis (director) and BERNARD Guy Ivan Marc (director)Appointment: AMARRIS HOLDING.BE (director) · Permanent representative: ROBIN Claude Gilbert André · Reappointment: CDP PETIT & Co SRL (statutory auditor)20 facts ▸
- General meeting, 30-06-2026
- Other provision, “première résolution - rapport spécial organe d’administration justification modification objet, sans réserves” (deed in French)
- Purpose change
- Amendment of the articles
- Other provision, “inscription registre public ITAA, personne morale reconnue comme société d’expert-comptable certifié” (deed in French)
- Capital
- Other provision, “TITRE IV : ADMINISTRATION - CONTROLE, titre statutaire” (deed in French)
- Director resignation, MEULEMAN Philippe Charles Louis (director)
- Director resignation, BERNARD Guy Ivan Marc (director)
- Director discharge, MEULEMAN Philippe Charles Louis
- Director discharge, BERNARD Guy Ivan Marc
- Board rule, 1
- +8 further facts in this act
28-02
Gazette deed
Appointment: CDP PETIT & Co (statutory auditor)Permanent representative: Benjamin Gorlier5 facts ▸
- General meeting, 22-09-2022
- Auditor appointment, CDP PETIT & Co (statutory auditor)
- Permanent representative, Benjamin Gorlier
- Board composition, Philippe MEULEMAN (director)
- Board composition, Guy BERNARD (director)
About the unread acts
Of the 5 Belgian Official Gazette deeds we know for this company, 2 have been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 29 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Recognitions · licences · registrations
Legal Entity Identifier
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 establishment unit
1 parcel
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 62817B0289/00P003 | Wallonia | 405 m² | 1 · 207 m² | 8.8 m · 3 |
How the parcels are linked
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “L'organisation de la comptabilité et des services comptables et les activités de conseil en matière d'organisation comptable des…” (deed in French)
12 activities (deed in French)
- L'organisation de la comptabilité et des services comptables et les activités de conseil en matière d'organisation comptable des entreprises;
- La détermination des résultats et l'établissement des comptes annuels conformément aux dispositions légales en la matière;
- L'ouverture, la tenue, la centralisation et la clôture des écritures comptables propres à l'établissement des comptes;
- La vérification et le redressement de tous les documents comptables qui ne conduisent pas à une attestation ou un rapport d'expertise destinés à être remis à des tiers;
- L'analyse par les procédés de la technique comptable de la situation et du fonctionnement des entreprises du point de vue de leur crédit, de leur rendement et de leurs risques qui ne conduit pas à une attestation ou un rapport d'expertise destinés à être remis à des tiers;
- L'expertise, tant privée que judiciaire, dans le domaine de la comptabilité des entreprises;
- Toute mission visée aux 4° à 6° exercée par un expert-comptable certifié autre que le professionnel habituel qui conduit à une attestation ou un rapport d'expertise destinés à être remis à des tiers;
- Les autres missions dont l'accomplissement est réservé par la loi ou en vertu de la loi à l'expert-comptable certifié;
- La délivrance d'avis se rapportant à toutes matières fiscales;
- L'assistance du contribuable dans l'accomplissement de ses obligations fiscales;
- La représentation du contribuable auprès de l'administration fiscale;
- L'organisation des services administratifs et le conseil sur l'organisation administrative des entreprises.
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- PHARMALEX
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Article 2, par simple décision organe d’administration établir ou supprimer sièges administratifs, agences, ateliers, dépôts et succursales…” (deed in French)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “Organe d'administration, Article 11” (deed in French)
Capital, shares and profit
- Kind of sharesWhich classes of shares exist and what rights each class carries.
- One provision in the deed
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “Droits de vote entre vifs et pour cause de mort, majorité des droits de vote détenue par experts-comptables certifiés et/ou équivalents…” (deed in French)
- Share issue ruleHow and by whom new shares can be issued.
- “Apport en numéraire avec émission de nouvelles actions-droit de préférence, courrier électronique,ou courrier ordinaire même jour si pas…” (deed in French)
- Membership ruleWho can become a member or partner, and on what terms.
- “Qualité d’actionnaire société d’expert-comptable certifié, Conseil de l’Institut” (deed in French)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Second Friday of December at 17:00
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Tout temps par assemblée générale délibérant formes modifications aux statuts” (deed in French)
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- One provision in the deed